The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on oral conditions represents a landmark moment for the community.1 For the first time, a comprehensive analysis of the ...

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

In their open-label, multicentre, randomised, non-inferiority trial of home-based ovulation monitoring in the management of frozen-thawed embryo transfers (FETs), Tjitske Zaat and colleagues showed ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...

Less than one-third of all the countries globally have regulations mandating Alcohol Health Warning Labels (AHWLs) on alcohol containers, said a late ...

Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...

At the pace with which the proportion of overweight people is growing, half of Nepal’s adult population will be obese by 2050 ...

Americas reveals a widening U.S. heart health divide, with wealthier, college-educated individuals facing lower heart disease ...

“This Lancet Commission study, part-funded by Alzheimer’s Society, identifies two new risk factors for developing dementia: ...

A new study warns that nearly 60% of adults and one-third of children worldwide will be overweight or obese by 2050 unless ...

A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...